tiprankstipranks
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Arcturus Therapeutics (ARCT) Income Statement

Compare
1,577 Followers

Arcturus Therapeutics Income Statement

Last quarter (Q3 2024), Arcturus Therapeutics's total revenue was $38.81M, a decrease of -10.52% from the same quarter last year. In Q3, Arcturus Therapeutics's net income was $-6.90M. See Arcturus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 157.75M$ 205.75M$ 12.36M$ 9.54M$ 20.79M
Gross Profit
$ 154.79M$ 62.70M$ -159.50M$ -46.41M$ -11.65M
Operating Expenses
$ 235.95M$ 193.58M$ 215.21M$ 81.06M$ 46.30M
Depreciation and Amortization
$ 2.96M$ 1.53M$ 1.19M$ 882.00K$ 684.00K
EBITDA
$ -24.17M$ 13.70M$ -201.66M$ -70.64M$ -24.42M
Operating Income
$ -78.20M$ 12.18M$ -202.85M$ -71.52M$ -25.51M
Other Income/Expenses
$ 50.31M$ -1.53M$ -822.00K$ -624.00K$ -478.00K
Pretax Income
$ -27.89M$ 10.64M$ -203.67M$ -72.15M$ -25.99M
Net Income
$ -29.73M$ 9.35M$ -206.86M$ -71.36M$ -25.72M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.12$ 0.35$ -7.86$ -3.51$ -2.13
Diluted EPS
$ -1.12$ 0.35$ -7.86$ -3.51$ -2.13
Weighted Average Shares Outstanding
26.63M 26.45M 26.32M 20.30M 12.07M
Weighted Average Shares Outstanding (Diluted)
26.63M 27.09M 26.32M 20.30M 12.07M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis